Cytrellis Biosystems
Woburn, Massachusetts, United States · Healthcare, Health Care
Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices which emphasize safety, efficacy, and improved quality of life for our patients. Cytrellis’ first product, the ellacor® System with Micro-Coring® Technology, is indicated for use by medical professionals for the treatment of moderate to severe wrinkles in the mid to lowe
Key facts
- Headquarters
- Woburn, Massachusetts, United States
- Employees
- 59
- Industries
- Healthcare, Health Care
- Status
- Private
- Website
- cytrellis.com
- Company page
Recent activity at Cytrellis Biosystems
Cytrellis Biosystems funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Venture | $25.1M |
| Jan 2021 | Venture | $50.0M |
Leadership
- KAREN CRONHOLM, Executive Officer, Director
- JOHN MCDONOUGH, Director
- KEITH CRANDELL, Director
- MICHAEL PETERSON, Director
- FREDERICK MD, Director
- FRED MD, Director
- Denise Wakelin, Director of Human Resources
- John Featherstone, Vice President of Sales
- DIANE MARCOU, Executive Officer
Verified email and direct lines for Cytrellis Biosystems’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Cytrellis Biosystems files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Cytrellis Biosystems in the news
- Cytrellis Announces Partnership for Commercialization of ellacor® Micro-Coring® Technology in South Korea - PR Newswire (Sep 29, 2026)
- Cytrellis Launches ellacor® Micro-Coring® Technology for Full-Body Skin Resurfacing in Australia - Morningstar (Aug 26, 2026)
- Cytrellis Named Strategic Industry Partner of Aesthetic Medicine Certificate Program at University of Miami Featuring ellacor® Micro-Coring® Technology - PR Newswire (Oct 30, 2026)
- U.S. FDA Clears Ellacor Micro-coring Technology for Full Body Resurfacing - The Dermatology Digest (Nov 06, 2025)
- Cytrellis Biosystems Completes $50 Million Series C Financing - PR Newswire (Sep 21, 2021)
Companies similar to Cytrellis Biosystems
- Lungpacer Medical · Healthcare, Health Care
- EnsoData · Healthcare, Health Care
- 410 Medical · Healthcare, Health Care
- Avertix Medical · Healthcare, Health Care
- Cognito Therapeutics · Healthcare, Health Care
About Cytrellis Biosystems: questions and answers
What does Cytrellis Biosystems do?
Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices which emphasize safety, efficacy, and improved quality of life for our patients. Cytrellis’ first product, the ellacor® System with Micro-Coring® Technology, is indicated for use by medical professionals for the treatment of moderate to severe wrinkles in the mid to lowe
Where is Cytrellis Biosystems headquartered?
Cytrellis Biosystems is headquartered in Woburn, Massachusetts, United States.
How many employees does Cytrellis Biosystems have?
Cytrellis Biosystems has about 59 employees.
Has Cytrellis Biosystems raised funding?
Yes. Fundz has recorded 2 funding events for Cytrellis Biosystems. The most recent, $25.1M, was in Dec 2024.
Who leads Cytrellis Biosystems?
John Featherstone is a Vice President of Sales at Cytrellis Biosystems.
What is the latest news on Cytrellis Biosystems?
On Dec 31, 2024, Cytrellis Biosystems
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy